Global Blood Group Typing Market Size, Share, and COVID-19 Impact Analysis, By Product (Consumables, Instruments, Services), Test Type (ABO, Antigen, Antibody, HLA), Technique (Assay-based, PCR, Microarray, Massively Parallel Sequencing), End User (Hospital, Blood Banks), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 - 2032
Industry: HealthcareGlobal Blood Group Typing Market Insights Forecasts to 2032
- The Global Blood Group Typing Market Size was valued at USD 1.78 Billion in 2022.
- The Market Size is Growing at a CAGR of 8.4% from 2022 to 2032
- The Worldwide Blood Group Typing Market Size is expected to reach USD 3.98 Billion by 2032
- Asia Pacific is expected to Grow the fastest during the forecast period
Get more details on this report -
The Global Blood Group Typing Market size is anticipated to exceed USD 3.98 Billion by 2032, growing at a CAGR of 8.4% from 2022 to 2032. As healthcare systems continue to prioritize patient safety and personalized medicine, emphasizing the importance of precise blood typing in modern healthcare practices, the global blood group typing market is expected to expand further.
Market Overview
The global blood group typing market is an evolving and important segment of the healthcare industry that is concerned with identifying and classifying blood groups within individuals. Blood group typing is important in a variety of medical settings, including blood transfusions, organ transplants, and prenatal care. This market includes a diverse range of products and services aimed at accurately determining an individual's blood type, ensuring compatibility and safety in medical procedures. Blood group typing entails categorizing blood into various groups, primarily the ABO and RhD systems, with subtypes such as A1, A2, B, and O. Typing accurately is critical for preventing adverse reactions during transfusions or transplants, lowering the risk of hemolytic reactions, and ensuring patient safety. As medical technology advances, the global blood group typing market has grown significantly, driven by an increasing demand for precise and rapid blood typing methods. Blood typing reagents, instruments, and testing services are important components of this market, which serves hospitals, blood banks, and diagnostic laboratories worldwide. Furthermore, advances in molecular biology and genetics have resulted in the development of molecular blood typing techniques, which have improved the accuracy and efficiency of blood group determination.
Report Coverage
This research report categorizes the market for the global blood group typing market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the blood group typing market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the blood group typing market.
Global Blood Group Typing Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2022 |
Market Size in 2022: | USD 1.78 Billion |
Forecast Period: | 2022-2032 |
Forecast Period CAGR 2022-2032 : | 8.4% |
2032 Value Projection: | USD 3.98 Billion |
Historical Data for: | 2018-2021 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 110 |
Segments covered: | By Product, By Region |
Companies covered:: | Quotient Limited, CareDx Inc., Agena Bioscience, Inc. (Mesa Laboratories, Inc.), DIAGAST, Illumina, Inc., Grifols, S.A., Immucor, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Merck KGaA, QIAGEN, Beckman Coulter, Inc. (Danaher), QuidelOrtho Corporation, And other key venders |
Pitfalls & Challenges: | COVID-19 Empact,Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The rising incidence of accidents, surgeries, and medical conditions requiring blood transfusions is a significant driver. Accurate blood typing is essential to prevent transfusion reactions, thereby boosting the demand for blood group typing products and services. Organ and tissue transplantation procedures are becoming more common worldwide. Accurate blood group matching is crucial to ensure transplant compatibility, driving the need for precise blood typing techniques. The expansion of healthcare infrastructure, particularly in emerging economies, has led to an increase in the number of blood banks and diagnostic labs. These facilities require reliable blood typing solutions to meet the growing demand for blood-related services. Increasing awareness about blood safety and the risks associated with incompatible transfusions has led to a greater emphasis on accurate blood typing. This awareness fuels the adoption of advanced blood typing technologies.
Restraining Factors
State-of-the-art blood typing technologies often come with a significant upfront cost. This can deter healthcare facilities, particularly in resource-constrained regions, from adopting advanced blood typing methods, limiting market growth. In many developing countries, access to advanced healthcare services, including blood typing, is limited. Economic disparities and inadequate infrastructure can hinder market expansion in these regions. In some regions, there may be limited awareness among healthcare professionals and the general population about the importance of accurate blood typing. This lack of awareness can slow the adoption of advanced blood typing methods.
Market Segmentation
The Global Blood Group Typing Market share is classified into product, and test type.
- The Services segment is expected to hold a significant share of the global blood group typing market during the forecast period.
The global blood group typing market is categorized by product into Consumables, Instruments, Services. Among these, the Services segment is expected to hold a significant share of the global blood group typing market during the forecast period. Because of the increased demand for accurate and timely blood typing results, services have grown in importance. Particularly for rare blood types or complex cases, reference laboratories play an important role in providing specialized blood typing services. Outsourcing blood typing tests to reference laboratories, contract blood typing services, and blood typing performed in hospitals and clinics by trained professionals are all services in the blood group typing market.
- The ABO segment is expected to hold a significant share of the global blood group typing market during the forecast period.
Based on the test type, the global blood group typing market is divided into ABO, Antigen, Antibody, HLA. Among these, the ABO segment is expected to hold a significant share of the global blood group typing market during the forecast period. The ABO blood grouping system is critical for ensuring the safety of blood transfusions and organ transplants. It serves as the foundation for blood compatibility testing and is a standard part of blood typing procedures, making it a significant market segment.
ABO blood grouping is the most fundamental blood typing system, classifying blood into four main groups: A, B, AB, and O, based on the presence or absence of specific antigens on the surface of red blood cells (RBCs).
Regional Segment Analysis of the Global Blood Group Typing Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America is anticipated to hold a significant share of the global blood group typing market over the predicted timeframe.
Get more details on this report -
North America is projected to hold a significant share of the global blood group typing market over the predicted years. A strong healthcare system, a large population, increasing surgical procedures, and stringent regulations promoting blood safety all contribute to North America's significant market share. North America, which includes the United States and Canada, frequently holds a sizable share of the global blood group typing market. The region benefits from a well-developed healthcare infrastructure, advanced medical technologies, and a high demand for blood typing services.
Asia Pacific is expected to grow at the fastest pace in the global blood group typing market during the forecast period. Expanding healthcare access, a large and diverse population, and the adoption of advanced medical technologies are all important factors in the region's growing market share. The blood group typing market in the Asia-Pacific region, which includes countries such as China, India, and Japan, is expanding rapidly. Market expansion is being driven by population growth, rising healthcare investments, and increased awareness.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global blood group typing along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Quotient Limited
- CareDx Inc.
- Agena Bioscience, Inc. (Mesa Laboratories, Inc.)
- DIAGAST
- Illumina, Inc.
- Grifols, S.A.
- Immucor, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- QIAGEN
- Beckman Coulter, Inc. (Danaher)
- QuidelOrtho Corporation
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In April 2023, Metropolis Healthcare introduced the 'NextGen HLA' Typing Test, which is integrated with next-generation sequencing technology to help identify donors for bone marrow, cord blood, or organ transplantation.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2032. Spherical Insights has segmented the Global Blood Group Typing Market based on the below-mentioned segments:
Global Blood Group Typing Market, By Product
- Consumables
- Instruments
- Services
Global Blood Group Typing Market, By Test Type
- ABO
- Antigen
- Antibody
- HLA
Global Blood Group Typing Market, By Technique
- Assay-based
- PCR
- Microarray
- Massively Parallel Sequencing
Global Blood Group Typing Market, By End User
- Hospital
- Blood Banks
Global Blood Group Typing Market, By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Need help to buy this report?